A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 46
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IBS-D
Long Form : IBS with diarrhea
No. Year Title Co-occurring Abbreviation
2019 Close association between abnormal expressed enzymes of energy metabolism and diarrhea-predominant irritable bowel syndrome. 2-DE, CT, ENOA, HPLC, IBS, MS
2018 Agomelatine, a novel therapeutic option for the management of irritable bowel syndrome. IBS
2018 Neuronal Nitric Oxide Synthase Is a Novel Biomarker for the Interstitial Cells of Cajal in Stress-Induced Diarrhea-Dominant Irritable Bowel Syndrome. IBS, ICC, NMS, nNOS
2018 Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation. HCs, IBS, IBS-C, WGCNA
2017 Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome. ARs, CRD, IBS, PDEs, WRS
2017 Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome. CT, IBS, IBS-C
2017 Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI. AUC, HV, IBS, IBS-C, IBS-M, IBS-nonC, MRI
2017 Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea. IBS
2017 Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea. BSFS, IBS
10  2017 Serotonin Transporter Gene (SLC6A4) Polymorphism and Mucosal Serotonin Levels in Southeastern Iranian Patients with Irritable Bowel Syndrome. ELISA, IBS, IBS-C, IBS-M, qPCR-HRM
11  2017 The gut peptide neuropeptide Y and post-traumatic stress disorder. IBS, NPY, PTSD, SNS
12  2017 The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS. FDA, NK2
13  2017 The place of eluxadoline in the management of irritable bowel syndrome with diarrhea. FDA, IBS
14  2017 [Changes of adherens junctions between the epithelial cells of intestinal mucosal barrier in irritable bowel syndrome]. AJ, E-cad, IBS, TEM
15  2016 A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). ---
16  2016 Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. IBS-C
17  2016 Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea. BMMCs, CINC, IBS, IL, iNOS, L-NAME, MCs, NO
18  2016 MicroRNA-199b expression level and coliform count in irritable bowel syndrome. IBS, miRNA
19  2016 Modern Management of Irritable Bowel Syndrome: More Than Motility. IBS
20  2016 Patterns of alternation in irritable bowel syndrome. IBS, IBS-C
21  2016 Possible therapeutic role of IgE blockade in irritable bowel syndrome. IBS, MCs
22  2016 Recommendations for pharmacological clinical trials in children with irritable bowel syndrome: the Rome foundation pediatric subcommittee on clinical trials. BSFS, IBS, IBS-C, RCI
23  2016 Serum immune biomarkers in irritable bowel syndrome. ELISA, GI, IBS, IBS-C, IBS-M, IL-6, IL-8, TNF-alpha
24  2015 An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries. CC, IBD, IBS, IBS-C
25  2015 Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea. IBS
26  2015 Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. HAMA, HAMD, IBS, QOL
27  2015 The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D). IBS
28  2014 Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. IBS, IBS-C
29  2014 Inhibitory effect of the selective serotonin 5-HT₃ receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats. FD, IBS, MAP
30  2014 Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. IBS, IBS-C
31  2014 Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial. IBS, IBS-QOL, IBS-SSS, SQTX Granule, TCM
32  2013 Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. IBS, IBS-C, UBA
33  2013 Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. IBS, IBS-C, IBS-M, PI-IBS, PYY
34  2013 Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFalpha. HVs, IBS, IBS-C, MAF, PI-IBS, SNPs
35  2012 Rifaximin for the treatment of irritable bowel syndrome. IBS
36  2012 Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. IBS, IBS-C
37  2011 Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults. BMI, CI, IBS, IBS-C, OR
38  2011 Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. IBS
39  2010 Functional bowel disorders in Iranian population using Rome III criteria. FBD, FC, FD, IBS, IBS-C, UFBD
40  2009 Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. CDC-4, FBDSI, HRQoL, IBS, IBS-C, IBS-QOL, IBSSS, PROOF, WPAI
41  2009 [A research of migrating motor complex in patients with irritable bowel syndrome]. DCC, IBS, IBS-C, MMC
42  2008 Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria. IBS, IBS-C
43  2006 A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. IBS, IBS-A, IBS-C
44  2006 Role of motility in chronic diarrhoea. CRF, HAPCs, IBS
45  2005 A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. IBS, IBS-C
46  2004 Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. IBS, IBS-C, UC